Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1999
12/02/1999WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/01/1999EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999EP0959883A1 Inhibitors of farnesyl-protein transferase
12/01/1999EP0959878A1 Method for treating renal failure
12/01/1999EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999CN1237177A Fused bicyclic pyrimidine derivatives
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237159A Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments
12/01/1999CN1236643A Medicine for curing impotence
12/01/1999CN1046942C Imidazopyridines
11/1999
11/30/1999US5994547 Process for preparing benzo[b]thiophenes
11/30/1999US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999US5994384 Hypersensitization of adrenergic receptors
11/30/1999US5994369 Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994344 Bronchitis therapy
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999059997A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
11/25/1999WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059816A1 Silicone sheet and surgical bandage manufactured using the same
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/24/1999EP0958282A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
11/24/1999EP0957924A1 Certain phosphinyl derivatives useful as naaladase inhibitors
11/24/1999EP0957907A1 Il-8 receptor antagonists
11/24/1999EP0550703B1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/23/1999US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/23/1999US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989581 Thermoplastic polymer core and skin containing steroidal progestogenic compound and steroidal estrogenic compound
11/23/1999CA2207694C Process for preparing sildenafil
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058478A1 Novel derivatives of 3,3-diphenylpropylamines
11/18/1999WO1999058001A1 Nutritional product for a person having renal failure
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/17/1999EP0957073A1 Novel derivatives of 3,3-diphenylpropylamines
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/16/1999US5986103 2-alkyl-1H-imidazole-5-carboxylic acids
11/16/1999US5985938 Method for reducing oxalate
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985886 Endothelin receptor antagonists
11/16/1999US5985885 Useful in the treatment of hypertension, congestive heart failure, prostate hypertrophy, various urinary tract disorders and pathological symptoms caused by hyperactivity or disfunctioning of the noradrenergic neural system
11/16/1999US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/11/1999WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999WO1999057293A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057131A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999056785A2 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction
11/11/1999WO1999056739A1 A method for chemoprevention of prostate cancer
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2327543A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999CA2326957A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/10/1999EP0955294A2 Imidazolyl-alkenoic acid
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954308A1 Therapeutic treatment for cardiovascular diseases
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999CN1234801A 3-methylamide derivatives of 5H-pyrrolo [2,1,-C] [1,4]-benzodiazepines
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234398A Process for preparing alpha-adrenergic aceptor antagonist
11/09/1999US5981563 Orally administering a rapidly dissolving tablet comprising phentolamine or its pharmaceutically acceptable salts
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 562